减重手术:使用趋势、并发症、转位与修正手术
该研究基于美国MarketScan商业保险理赔数据库,纳入2000至2020年接受减重手术且连续参保至少6个月的成人,共识别349411例减重手术和5521例转位或修正手术;袖状胃切除术(SG)量在2018年开始下降而Roux-en-Y胃旁路术(RYGB)保持稳定;与RYGB相比,SG的1年再入院、脱水、恶心呕吐、吞咽困难和消化道出血发生率更低,但内镜检查、烧心、胃炎、门静脉血栓和各类疝的发生率更高。
要点
- 理赔数据库中减重手术总量在过去10年呈下降趋势。
- SG比例下降而RYGB比例上升,提示SG特有并发症可能驱动该趋势。
- 与RYGB相比,SG的1年再入院aHR为0.65(95%CI 0.64-0.68)。
核心结论
- 理赔数据库中减重手术总体量在过去10年呈下降趋势。
- SG比例下降而RYGB比例上升,提示SG特有并发症可能驱动该趋势。
- RYGB应继续作为减重外科医生的重要工具。
研究设计与样本
- 基于美国MarketScan商业理赔与 encounter 数据库的行政理赔数据分析。
- 纳入2000至2020年接受减重手术且连续参保至少6个月的成人。
- 共识别349411例减重手术和5521例转位或修正手术。
- 采用稳定逆概率治疗加权Kaplan-Meier分析比较并发症累积发生率。
主要发现
- 样本中SG量似乎从2018年开始下降,而RYGB保持稳定。
- 与RYGB相比,SG的1年发生率更低:30天再入院aHR 0.65(95%CI 0.64-0.68)、脱水0.75(0.73-0.78)、恶心或呕吐0.70(0.69-0.72)、吞咽困难0.55(0.53-0.57)、消化道出血0.43(0.40-0.46)。
- 与RYGB相比,SG的1年发生率更高:食管胃十二指肠镜aHR 1.13(95%CI 1.11-1.15)、烧心1.38(1.28-1.49)、胃炎4.28(4.14-4.44)、门静脉血栓3.93(2.82-5.48)、各类疝1.36(1.34-1.39)。
- 从SG转位至RYGB的手术多于再次袖状胃切除术。
- 与RYGB相比,SG的其他非修正性外科干预1年发生率显著更低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Sleeve gastrectomy (SG) increased in popularity after 2010 but recent data suggest it has concerning rates of gastroesophageal reflux and need for conversions. This study aims to evaluate recent trends in the utilization of bariatric procedures, associated complications, and conversions using an administrative claims database in the United States. METHODS: We included adults who had bariatric procedures from 2000 to 2020 with continuous enrollment for at least 6 months in the MarketScan Commercial Claims and Encounters database. Index bariatric procedures and subsequent revisions or conversions were identified using CPT codes. Baseline comorbidities and postoperative complications were identified with ICD-9-CM and ICD-10 codes. Cumulative incidences of complications were estimated at 30-days, 6-months, and 1-year and compared with stabilized inverse probability of treatment weighted Kaplan-Meier analysis. RESULTS: We identified 349,411 bariatric procedures and 5521 conversions or revisions. The sampled SG volume appeared to begin declining in 2018 while Roux-en-Y gastric bypass (RYGB) remained steady. Compared to RYGB, SG was associated with lower 1-year incidence [aHR, (95% CIs)] for 30-days readmission [0.65, (0.64-0.68)], dehydration [0.75, (0.73-0.78)], nausea or vomiting [0.70, (0.69-0.72)], dysphagia [0.55, (0.53-0.57)], and gastrointestinal hemorrhage [0.43, (0.40-0.46)]. Compared to RYGB, SG was associated with higher 1-year incidence [aHR, (95% CIs)] of esophagogastroduodenoscopy [1.13, (1.11-1.15)], heartburn [1.38, (1.28-1.49)], gastritis [4.28, (4.14-4.44)], portal vein thrombosis [3.93, (2.82-5.48)], and hernias of all types [1.36, (1.34-1.39)]. There were more conversions from SG to RYGB than re-sleeving procedures. SG had a significantly lower 1-year incidence of other non-revisional surgical interventions when compared to RYGB. CONCLUSIONS: The overall volume of bariatric procedures within the claims database appeared to be declining over the last 10 years. The decreasing proportion of SG and the increasing proportion of RYGB suggest the specific complications of SG may be driving this trend. Clearly, RYGB should remain an important tool in the bariatric surgeon's armamentarium.
引用
- Hsu JL, Ismail S, Hodges MM, et al. Bariatric surgery: trends in utilization, complications, conversions and revisions. Surg Endosc. 2024. PMID: 38902405. doi:10.1007/s00464-024-10985-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。